Healthcare Sales & Marketing Network News: XTL Biopharmaceuticals

Searching News Database: XTL Biopharmaceuticals

HSMN NewsFeed - 1 Jun 2011
FDA Grants Orphan Drug Designation for XTL's rHuEPO Treatment for Multiple Myeloma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 28 Mar 2011
XTL Biopharmaceuticals to Acquire MinoGuard Ltd.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 20 May 2009
Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 May 2008
XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Mar 2008
Presidio Pharmaceuticals Obtains Exclusive Worldwide Rights to XTL Biopharmaceuticals Ltd. Hepatitis C Virus (HCV) NS5A Program
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Mar 2008
XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
Biopharmaceuticals Licensing

HSMN NewsFeed - 16 Jan 2007
XTL Biopharmaceuticals Announces the In-Licensing of Bicifadine - A Late-Stage Clinical Compound for the Treatment of Neuropathic Pain
Biopharmaceuticals Licensing

HSMN NewsFeed - 6 Jul 2006
XTL Biopharmaceuticals, Ltd. Announces Managerial Change
Biopharmaceuticals Personnel

Return to NewsFeed

Additional items found! 22

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 22 additional stories matching:
XTL Biopharmaceuticals
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.